499 related articles for article (PubMed ID: 16253494)
1. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
Manuel Porcel J; Vives M; Esquerda A; Ruiz A
Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
[TBL] [Abstract][Full Text] [Related]
2. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
3. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing pleural drainage in parapneumonic effusions.
Porcel JM; Valencia H; Bielsa S
Rev Clin Esp (Barc); 2016 Oct; 216(7):361-366. PubMed ID: 27161381
[TBL] [Abstract][Full Text] [Related]
5. Parapneumonic effusions and empyema.
Light RW
Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
[TBL] [Abstract][Full Text] [Related]
6. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
Tsujimoto N; Saraya T; Light RW; Tsukahara Y; Koide T; Kurai D; Ishii H; Kimura H; Goto H; Takizawa H
PLoS One; 2015; 10(6):e0130141. PubMed ID: 26076488
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of C-reactive protein in parapneumonic effusions.
Skouras V; Boultadakis E; Nikoulis D; Polychronopoulos V; Daniil Z; Kalomenidis I; Gourgoulianis KI
Respirology; 2012 Feb; 17(2):308-14. PubMed ID: 21995428
[TBL] [Abstract][Full Text] [Related]
8. [Pleural effusion and empyema as complications of pneumonia].
Bauwens AM; de Graaff CS; Boersma WG
Ned Tijdschr Geneeskd; 2002 Mar; 146(10):464-9. PubMed ID: 11913110
[TBL] [Abstract][Full Text] [Related]
9. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions.
Bielsa S; Valencia H; Ruiz-González A; Esquerda A; Porcel JM
Lung; 2014 Aug; 192(4):577-81. PubMed ID: 24913743
[TBL] [Abstract][Full Text] [Related]
10. Pleural fluid tests to identify complicated parapneumonic effusions.
Porcel JM
Curr Opin Pulm Med; 2010 Jul; 16(4):357-61. PubMed ID: 20224408
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of parapneumonic effusions and empyema.
Sahn SA
Clin Infect Dis; 2007 Dec; 45(11):1480-6. PubMed ID: 17990232
[TBL] [Abstract][Full Text] [Related]
12. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema.
Wu KA; Wu CC; Liu YC; Hsueh PC; Chin CY; Wang CL; Chu CM; Shih LJ; Yang CY
BMC Pulm Med; 2019 Jun; 19(1):108. PubMed ID: 31215423
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
Porcel JM; Vives M; Esquerda A
Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
[TBL] [Abstract][Full Text] [Related]
14. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions.
San José ME; Ferreiro L; Soneira ME; González-Barcala FJ; Vázquez MC; Golpe A; Valdés L
Am J Clin Pathol; 2014 Oct; 142(4):467-73. PubMed ID: 25239413
[TBL] [Abstract][Full Text] [Related]
15. New trends in the diagnosis and treatment in parapneumonic effusion and empyema.
Na MJ; Dikensoy O; Light RW
Tuberk Toraks; 2008; 56(1):113-20. PubMed ID: 18330766
[TBL] [Abstract][Full Text] [Related]
16. Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema.
Yang CY; Kuo YH; Chen M; Wang CL; Shih LJ; Liu YC; Hsueh PC; Lai YH; Chu CM; Wu CC; Wu KA
Sci Rep; 2021 Jan; 11(1):1763. PubMed ID: 33469074
[TBL] [Abstract][Full Text] [Related]
17. [Parapneumonic pleural effusions and empyema in adults:current practice].
Porcel JM; Light RW
Rev Clin Esp; 2009 Nov; 209(10):485-94. PubMed ID: 19889319
[TBL] [Abstract][Full Text] [Related]
18. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
19. Pleural fluid parameters identifying complicated parapneumonic effusions.
Jiménez Castro D; Díaz Nuevo G; Sueiro A; Muriel A; Pérez-Rodríguez E; Light RW
Respiration; 2005; 72(4):357-64. PubMed ID: 16088277
[TBL] [Abstract][Full Text] [Related]
20. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
